RPRX
Royalty Pharma plc
$53.98
-$0.52(-0.96%)
71
Overall
100
Value
60
Tech
55
Quality
Market Cap
$16.52B
Volume
1.14M
52W Range
$32.21 - $54.64
Target Price
$59.57
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $2.1B | $2.3B | $2.2B | $2.4B | $2.3B | $2.4B | ||
| Total Revenue | $2.1B | $2.3B | $2.2B | $2.4B | $2.3B | $2.4B | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $2.1B | $2.3B | $2.2B | $2.4B | $2.3B | $2.4B | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $296.1M | $405.9M | $1.3B | $301.7M | $238.7M | $1.0B | ||
| Research & Development | $26.3M | $200.1M | $177.1M | $52.0M | $2.0M | $452.0M | ||
| Research Expense | $26.3M | $200.1M | $177.1M | $52.0M | $2.0M | $452.0M | ||
| Selling, General & Administrative | $181.7M | $182.8M | $227.3M | $249.7M | $236.7M | $573.5M | ||
| General & Administrative Expenses | $181.7M | $182.8M | $227.3M | $249.7M | $236.7M | $573.5M | ||
| Salaries & Wages | $5.4M | $2.4M | $2.2M | -- | -- | -- | ||
| Depreciation & Amortization | $23.1M | $23.0M | $5.7M | -- | -- | -- | ||
| Depreciation & Amortization | $23.1M | $23.0M | $5.7M | -- | -- | -- | ||
| Amortization | $23.1M | $23.0M | $5.7M | $20.5M | $19.6M | -- | ||
| Other Operating Expenses | $65.1M | -- | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $1.6B | $1.4B | $307.1M | $1.5B | $1.3B | $1.6B | ||
| EBITDA | $1.9B | $1.4B | $418.0M | $1.9B | $1.6B | $1.6B | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $157.1M | $166.1M | $188.0M | $187.2M | $225.5M | $307.7M | ||
| Intinc | -- | -- | -- | $72.3M | $47.3M | $33.6M | ||
| Net Non-Operating Interest Income/Expense | $-157.1M | $-619.0M | $109.6M | $-675.6M | $-910.6M | $21.8M | ||
| Gain on Sale of Securities | $-13.7M | $32.0M | $174.9M | $-2.3M | $-6.0M | -- | ||
| Other Income/Expense | $-263.6M | $23.4M | $-583.2M | $-322.8M | $-216.5M | $-38.7M | ||
| Other Special Charges | $-32.8M | $-5.7M | $-14.8M | $-21.7M | $-1.5M | $-14.3M | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | $-74.7M | $-4.5M | $-615.8M | $-20.9M | $-1.1M | -- | ||
| Impairment of Capital Assets | $65.1M | -- | $615.8M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $1.9B | $1.4B | $418.0M | $1.9B | $1.6B | $1.6B | ||
| Pre-Tax Income | $1.7B | $1.2B | $230.1M | $1.7B | $1.3B | $1.3B | ||
| NET INCOME | ||||||||
| Net Income | $975.0M | $619.7M | $42.8M | $1.1B | $859.0M | $770.9M | ||
| Net Income (Continuing Operations) | $975.0M | $619.7M | $230.1M | $1.7B | $1.3B | $1.3B | ||
| Net Income (Discontinued Operations) | $975.0M | $619.7M | $42.8M | $1.1B | $859.0M | $770.9M | ||
| Net Income (Common Stockholders) | $495.2M | $619.7M | $42.8M | $1.1B | $859.0M | $770.9M | ||
| Normalized Income | $1.4B | -- | -- | -- | -- | $1.3B | ||
| TOTALS | ||||||||
| Total Expenses | $296.1M | $405.9M | $1.3B | $301.7M | $238.7M | $1.0B | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $375.4M | $414.8M | $438.0M | $447.6M | $448.2M | $429.8M | ||
| Average Shares Outstanding (Diluted) | $375.5M | $414.8M | $438.0M | $602.9M | $594.1M | $564.5M | ||
| Shares Outstanding | $607.1M | $607.2M | $607.2M | $597.4M | $576.5M | $576.9M | ||
| Basic EPS | $1.32 | $1.49 | $0.10 | $2.54 | $1.92 | $1.79 | ||
| Basic EPS (Continuing Operations) | $1.32 | $1.49 | $0.10 | $2.54 | $1.92 | $1.79 | ||
| Diluted EPS | $1.32 | $1.49 | $0.10 | $2.53 | $1.91 | $1.78 | ||
| Diluted EPS (Continuing Operations) | $1.32 | $1.49 | $0.10 | $2.53 | $1.91 | $1.78 | ||
| Dividend Per Share | $0.60 | $0.68 | $0.76 | $0.80 | -- | -- | ||
| OTHER METRICS | ||||||||
| Earnings from equity interest | $44.5M | $-19.5M | $-9.0M | $28.9M | $29.6M | $29.1M | ||
| Earnings From Equity Interest Net Of Tax | $44.5M | $-19.5M | $-9.0M | $28.9M | $29.6M | $29.1M | ||
| Minority Interests | $-726.9M | $-621.5M | $-187.2M | $-565.3M | $-471.8M | $-553.2M | ||
| Net Income Discontinuous Operations | $-230.8M | $-452.8M | -- | -- | -- | -- | ||
| Other Gand A | $181.7M | $182.8M | $227.3M | $249.7M | $236.7M | $573.5M | ||
| Provision For Gain Loss On Disposal | $-230.8M | $-452.8M | -- | -- | -- | -- | ||
| Othspecchg | $9.6M | $4.5M | $11.1M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $53.98 | -1.0% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |